University Health Network

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1999-01-01

Employees: 10K

Market Cap: -

Website: http://www.uhn.ca

Clinical Trials

Lenalidomide & High Dose Dexamethasone for Untreated Multiple Myeloma Renal Failure Patients

Phase 2

Completed

Conditions: Renal Failure
Multiple Myeloma

Interventions: Drug: Lenalidomide and Dexamethasone

First Posted Date: 2011-01-05

Last Posted Date: 2017-12-29

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 28

Registration Number: NCT01270932

Locations: 🇨🇦
University Health Network- Princess Margaret Hosptial, Toronto, Ontario, Canada

To Evaluate the Safety and Metabolic Profile of Vyvanse for the Treatment of ADHD in Euthymic Adults With Bipolar I/II Disorder

Completed

Conditions: Attention Deficit/Hyperactivity Disorder
Bipolar Disorder

Interventions: Drug: lisdexamfetamine dimesylate

First Posted Date: 2010-12-20

Last Posted Date: 2012-06-01

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 45

Registration Number: NCT01263548

Locations: 🇨🇦
Mood Disorders Psychopharmacology Unit, Toronto, Ontario, Canada

Can Ultrasound Detect Diabetic Peripheral Neuropathy?

Completed

Conditions: Distal Symmetric Polyneuropathy (DSPN)

Interventions: Procedure: Nerve Conduction Study (NCS)

First Posted Date: 2010-12-16

Last Posted Date: 2012-04-26

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 100

Registration Number: NCT01261442

Locations: 🇨🇦
Toronto Western Hospital, Toronto, Ontario, Canada

Prospective Randomized Pilot Study Comparing Inferior Versus Superior Conjunctival Autografts for Primary Pterygia

Not Applicable

Conditions: Pterygium

Interventions: Procedure: Location of the autograft taken following pterygium excision

First Posted Date: 2010-12-16

Last Posted Date: 2010-12-16

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 40

Registration Number: NCT01261455

Locations: 🇨🇦
Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada

A Study of Perioperative Chemotherapy Plus Panitumumab in Patients With Colorectal Cancer Liver Metastases

Phase 2

Completed

Conditions: Colorectal Cancer
Liver Metastases

Interventions: Drug: Panitumumab, Oxaliplatin, 5-FU

First Posted Date: 2010-12-15

Last Posted Date: 2019-05-14

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 11

Registration Number: NCT01260415

Locations: 🇨🇦
London Regional Cancer Centre, London, Ontario, Canada
🇨🇦
Mount Sinai Hospital, Toronto, Ontario, Canada
🇨🇦
Princess Margaret Hospital, Toronto, Ontario, Canada

and more 1 locations

Inhaled Nitric Oxide for the Adjunctive Therapy of Severe Malaria: a Randomized Controlled Trial

Phase 1

Completed

Conditions: Severe Malaria

Interventions: Drug: Inhaled Nitric Oxide

First Posted Date: 2010-12-07

Last Posted Date: 2014-02-20

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 180

Registration Number: NCT01255215

Locations: 🇺🇬
Jinja Regional Referral Hospital, Jinja, Uganda

Comparison of Primovist-enhanced MRI, Diffusion Weighted MRI and Multidetector CT of Colorectal Liver Metastases

Not Applicable

Completed

Conditions: Colorectal Liver Metastases

Interventions: Other: MR imaging

First Posted Date: 2010-12-07

Last Posted Date: 2015-01-07

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 50

Registration Number: NCT01255007

Locations: 🇨🇦
University Health Network-Princess Margaret Hospital, Toronto, Ontario, Canada

Safety and Efficacy Study of Inhaled AmBisome for Prevention of Aspergillus Colonization in Lung Transplant Recipients

Phase 2

Suspended

Conditions: Lung Transplant Recipient

Interventions: Drug: Regular standard of care medication
Drug: Ambisome ®

First Posted Date: 2010-12-06

Last Posted Date: 2011-10-19

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 4

Registration Number: NCT01254708

Locations: 🇨🇦
University Health Network/ Toronto General Hospital, Toronto, Ontario, Canada

The Effectiveness of Perioperative CPAP to Reduce Obstructive Sleep Apnea Related Adverse Events

Not Applicable

Completed

Conditions: Obstructive Sleep Apnea (OSA)

Interventions: Device: auto-titrated CPAP
Device: Control

First Posted Date: 2010-11-30

Last Posted Date: 2013-12-18

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 120

Registration Number: NCT01249924

Locations: 🇨🇦
Toronto Western Hospital, Department of Aneshtesia, Toronto, Ontario, Canada
🇨🇦
Mount Sinai Hospital, Department of Anesthesia, Toronto, Ontario, Canada

Sub-tenon Triamcinolone Acetonide in Age-Related Macular Degeneration as Adjunct to Ranibizumab

Phase 2

Conditions: Wet Macular Degeneration

Interventions: Drug: Ranibizumab
Drug: Triamcinolone Acetonide

First Posted Date: 2010-11-30

Last Posted Date: 2011-02-09

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 30

Registration Number: NCT01249937

Locations: 🇨🇦
University Health Network-Toronto Western Hospital, Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy